Background: Whilst bony fixation of hip replacement has stable solutions, there remains controversy over which bearing best optimizes longevity and function. Ceramic-on-ceramic (CoC) bearing combinations are associated with lower risk of revision due to aseptic loosening and dislocation. Evidence for long-term functional outcomes of modern, 4th generation CoC bearings is limited. The aim of this study was to analyze outcomes and complications of the R3™ Acetabular System (Smith & Nephew, Inc., Cordova, TN, USA) in combination with BIOLOX® Delta ceramic femoral head in patients undergoing primary total hip arthroplasty (THA).
Methods: Between June 2009 and May 2011, 175 patients (178 hips) were enrolled into a prospective, study at 6 sites in Europe and prospectively followed-up at 3 months and 1, 3, 5, and 7 years postoperative.
Results: Total WOMAC score improved from 63 (range, 22-91) preoperative to 8 (range, 0- 8) at 1-year follow-up and remained unchanged at 7-year follow-up. Modified Harris Hip Score improved from 45 (range, 10-87) preoperative to 83 (range, 25-100) at 3 months, 91 (range, 42-100) at 1 year, and 92 (range, 46, 100) at 7 years. UCLA Activity Rating Scale score improved from 3.3 (range, 1-8) preoperative to 6.2 (range, 2-8) at 1 year; it marginally declined to 5.8 (range, 3-8) at 7-year follow-up. There were 4 trochanteric fractures and 5 patients died of unrelated reasons. Three hips were revised (2 periprosthetic fractures and 1 subluxation). The 7-year cumulative survival rate was 98.3%.
Conclusion: Clinical and functional improvements of THA with CoC bearing are maintained at 7 years postoperative.
Trial registration: ClinicalTrials.Gov, NCT03566082, Registered 10 January 2018 - Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT03566082
Figure 1
Figure 2
Figure 3
Figure 4
Loading...
Posted 04 Jan, 2021
On 09 Jan, 2021
On 26 Dec, 2020
On 16 Dec, 2020
On 16 Dec, 2020
On 16 Dec, 2020
On 31 Aug, 2020
Received 25 Aug, 2020
On 13 Aug, 2020
Received 28 Jul, 2020
On 17 Jul, 2020
Invitations sent on 16 Jul, 2020
On 13 Jul, 2020
On 12 Jul, 2020
On 12 Jul, 2020
On 08 Jul, 2020
Posted 04 Jan, 2021
On 09 Jan, 2021
On 26 Dec, 2020
On 16 Dec, 2020
On 16 Dec, 2020
On 16 Dec, 2020
On 31 Aug, 2020
Received 25 Aug, 2020
On 13 Aug, 2020
Received 28 Jul, 2020
On 17 Jul, 2020
Invitations sent on 16 Jul, 2020
On 13 Jul, 2020
On 12 Jul, 2020
On 12 Jul, 2020
On 08 Jul, 2020
Background: Whilst bony fixation of hip replacement has stable solutions, there remains controversy over which bearing best optimizes longevity and function. Ceramic-on-ceramic (CoC) bearing combinations are associated with lower risk of revision due to aseptic loosening and dislocation. Evidence for long-term functional outcomes of modern, 4th generation CoC bearings is limited. The aim of this study was to analyze outcomes and complications of the R3™ Acetabular System (Smith & Nephew, Inc., Cordova, TN, USA) in combination with BIOLOX® Delta ceramic femoral head in patients undergoing primary total hip arthroplasty (THA).
Methods: Between June 2009 and May 2011, 175 patients (178 hips) were enrolled into a prospective, study at 6 sites in Europe and prospectively followed-up at 3 months and 1, 3, 5, and 7 years postoperative.
Results: Total WOMAC score improved from 63 (range, 22-91) preoperative to 8 (range, 0- 8) at 1-year follow-up and remained unchanged at 7-year follow-up. Modified Harris Hip Score improved from 45 (range, 10-87) preoperative to 83 (range, 25-100) at 3 months, 91 (range, 42-100) at 1 year, and 92 (range, 46, 100) at 7 years. UCLA Activity Rating Scale score improved from 3.3 (range, 1-8) preoperative to 6.2 (range, 2-8) at 1 year; it marginally declined to 5.8 (range, 3-8) at 7-year follow-up. There were 4 trochanteric fractures and 5 patients died of unrelated reasons. Three hips were revised (2 periprosthetic fractures and 1 subluxation). The 7-year cumulative survival rate was 98.3%.
Conclusion: Clinical and functional improvements of THA with CoC bearing are maintained at 7 years postoperative.
Trial registration: ClinicalTrials.Gov, NCT03566082, Registered 10 January 2018 - Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT03566082
Figure 1
Figure 2
Figure 3
Figure 4
Loading...